These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 27033186)

  • 1. Rational Design of Multi-Target Estrogen Receptors ERα and ERβ by QSAR Approaches.
    Zhao Q; Lu Y; Zhao Y; Li R; Luan F; Cordeiro MN
    Curr Drug Targets; 2017; 18(5):576-591. PubMed ID: 27033186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of putative estrogen receptor-mediated endocrine disrupting chemicals using QSAR- and structure-based virtual screening approaches.
    Zhang L; Sedykh A; Tripathi A; Zhu H; Afantitis A; Mouchlis VD; Melagraki G; Rusyn I; Tropsha A
    Toxicol Appl Pharmacol; 2013 Oct; 272(1):67-76. PubMed ID: 23707773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of ligand selectivity using reporter cell lines stably expressing estrogen receptor alpha or beta.
    Escande A; Pillon A; Servant N; Cravedi JP; Larrea F; Muhn P; Nicolas JC; Cavaillès V; Balaguer P
    Biochem Pharmacol; 2006 May; 71(10):1459-69. PubMed ID: 16554039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen receptors: therapies targeted to receptor subtypes.
    Nilsson S; Gustafsson JÅ
    Clin Pharmacol Ther; 2011 Jan; 89(1):44-55. PubMed ID: 21124311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In silico prediction of estrogen receptor subtype binding affinity and selectivity using statistical methods and molecular docking with 2-arylnaphthalenes and 2-arylquinolines.
    Wang Z; Li Y; Ai C; Wang Y
    Int J Mol Sci; 2010 Sep; 11(9):3434-58. PubMed ID: 20957105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting estrogen receptor subtypes (ERα and ERβ) with selective ER modulators in ovarian cancer.
    Chan KK; Leung TH; Chan DW; Wei N; Lau GT; Liu SS; Siu MK; Ngan HY
    J Endocrinol; 2014 May; 221(2):325-36. PubMed ID: 24819599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indole-3-carbinol selectively uncouples expression and activity of estrogen receptor subtypes in human breast cancer cells.
    Sundar SN; Kerekatte V; Equinozio CN; Doan VB; Bjeldanes LF; Firestone GL
    Mol Endocrinol; 2006 Dec; 20(12):3070-82. PubMed ID: 16901971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of potent ligands for estrogen receptor beta by structure-based virtual screening.
    Shen J; Tan C; Zhang Y; Li X; Li W; Huang J; Shen X; Tang Y
    J Med Chem; 2010 Jul; 53(14):5361-5. PubMed ID: 20553023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phytoestrogens and their human metabolites show distinct agonistic and antagonistic properties on estrogen receptor alpha (ERalpha) and ERbeta in human cells.
    Mueller SO; Simon S; Chae K; Metzler M; Korach KS
    Toxicol Sci; 2004 Jul; 80(1):14-25. PubMed ID: 15084758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selenophenes: Introducing a New Element into the Core of Non-Steroidal Estrogen Receptor Ligands.
    Zhang S; Wang Z; Hu Z; Li C; Tang C; Carlson KE; Luo J; Dong C; Katzenellenbogen JA; Huang J; Zhou HB
    ChemMedChem; 2017 Feb; 12(3):235-249. PubMed ID: 27976818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissecting physiological roles of estrogen receptor alpha and beta with potent selective ligands from structure-based design.
    Hillisch A; Peters O; Kosemund D; Müller G; Walter A; Schneider B; Reddersen G; Elger W; Fritzemeier KH
    Mol Endocrinol; 2004 Jul; 18(7):1599-609. PubMed ID: 15105439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-based quantitative structure--activity relationship modeling of estrogen receptor β-ligands.
    Dong X; Hilliard SG; Zheng W
    Future Med Chem; 2011 Jun; 3(8):933-45. PubMed ID: 21707397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Descriptor analysis of estrogen receptor β-selective ligands using 2-phenylquinoline, tetrahydrofluorenone and 3-hydroxy 6H-benzo[c]chromen-6-one scaffolds.
    Balaji ; Muthiah R; Sabarinath ; Ramamurthy ; Chandrasekharan
    J Enzyme Inhib Med Chem; 2011 Dec; 26(6):831-42. PubMed ID: 21438712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure activity relationships and differential interactions and functional activity of various equine estrogens mediated via estrogen receptors (ERs) ERalpha and ERbeta.
    Bhavnani BR; Tam SP; Lu X
    Endocrinology; 2008 Oct; 149(10):4857-70. PubMed ID: 18599548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of natural estrogen receptor modulators with structure-based virtual screening.
    Cao X; Jiang J; Zhang S; Zhu L; Zou J; Diao Y; Xiao W; Shan L; Sun H; Zhang W; Huang J; Li H
    Bioorg Med Chem Lett; 2013 Jun; 23(11):3329-33. PubMed ID: 23608764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and synthesis of carborane-containing estrogen receptor-beta (ERβ)-selective ligands.
    Ohta K; Ogawa T; Oda A; Kaise A; Endo Y
    Bioorg Med Chem Lett; 2015 Oct; 25(19):4174-8. PubMed ID: 26298498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biochemical characterization of a series of 17α-perfluoroalkylated estradiols as selective ligands for estrogen receptor α.
    Eignerová B; Sedlák D; Dracínský M; Bartunek P; Kotora M
    J Med Chem; 2010 Oct; 53(19):6947-53. PubMed ID: 20812681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The estrogen receptor beta-isoform (ERbeta) of the human estrogen receptor modulates ERalpha transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens.
    Hall JM; McDonnell DP
    Endocrinology; 1999 Dec; 140(12):5566-78. PubMed ID: 10579320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen signaling: a subtle balance between ER alpha and ER beta.
    Matthews J; Gustafsson JA
    Mol Interv; 2003 Aug; 3(5):281-92. PubMed ID: 14993442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyrazolo[1,5-a]pyrimidines: estrogen receptor ligands possessing estrogen receptor beta antagonist activity.
    Compton DR; Sheng S; Carlson KE; Rebacz NA; Lee IY; Katzenellenbogen BS; Katzenellenbogen JA
    J Med Chem; 2004 Nov; 47(24):5872-93. PubMed ID: 15537344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.